This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

CAMHS won't see you now

Guideline of the month - updated guidance on abnormal LFTs

Here’s the guideline you should know about in January

The guideline

The British Society of Gastroenterology has published an extensive update of its 2000 guidance on the management of abnormal liver blood tests. It covers how an abnormal test should be defined, what should be included in a liver blood panel and managing abnormal results.

Key points for GPs

  • Initial tests should include bilirubin, albumin, alanine aminotransferase, alkaline phosphatase and γ-glutamyltransferase, as well as an FBC if not done in the previous 12 months.
  • Abnormal tests should be interpreted after a review of previous results, medical history and current symptoms.
  • The degree of abnormality doesn’t necessarily correlate with clinical significance – this depends on which analyte is outside the reference range.
  • Any abnormal results should prompt consideration of a liver aetiology screen. In adults this should include abdominal ultrasound, hepatitis B surface antigen and hepatitis C antibody.
  • Children should have an autoantibody panel with antiliver kidney microsomal antibody, coeliac antibodies, and, in over-threes, α-1-antitrypsin level and caeruloplasmin. Abnormalities should be discussed with an inherited metabolic disease specialist.
  • Adults with abnormal LFTs, even with a negative aetiology screen and no risk factors for non-alcoholic fatty liver disease, should be discussed with a gastroenterologist.

Practical issues

Given the importance given to the clinical context, GPs must take care to review the patient’s history and use their clinical judgement to determine the need for further investigation, discussing the case with a specialist if appropriate.

Expert comment

Dr Jez Thompson, Bradford GP and the British Liver Trust/RCGP clinical champion for liver disease, said: ‘This recommends assessment pathways that are not part of routine general practice, but they would be fairly easy to embed in primary care systems. Liver disease is the only major cause of death with a rising incidence and primary care has a key role in identifying risk factors, and providing interventions.’

The guideline

British Society of Gastroenterology. Guidelines on the management of abnormal liver blood tests. London; BSG: 2017

Related images

  • fatty liver gotm 3x2

Rate this article  (2.57 average user rating)

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Readers' comments (6)

  • "Adults with abnormal LFTs [...] should be discussed with a gastroenterologist."

    Prevalance of abnormal LFT is about 10%

    That is potentially 600 million patients to discuss with our gastro colleagues. I hope we get extra funding.

    Unsuitable or offensive? Report this comment

  • David Banner

    Agree with Dylan above.

    “Discuss every adult with abnormal LFT with gastroenterologist”

    So there will be a hotline to an army of otherwise unemployed gastroenterologists ready to take many thousands of calls every day from anxious GPs about a marginally raised ALT or GGT will there? Thought not. What an utterly useless guideline. And when Primary Care is run by PAs (who will actually follow these idiotic risk averse guidelines) the system will grind to a halt.

    Unsuitable or offensive? Report this comment

  • @ Dylon 5:02pm - you mean 6 million patients?.. not 600 million!!

    Unsuitable or offensive? Report this comment

  • This is totally ridiculous. Who makes these guidelines?

    Unsuitable or offensive? Report this comment

  • Plain stupid. Nil else.

    Unsuitable or offensive? Report this comment

  • @Dr Matt


    My brain confidently informed me there were 6 billion people living in the UK. My brain may have got mixed up.

    Unsuitable or offensive? Report this comment

Have your say